Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 380.41Cr 440.59Cr 56Cr 49Cr 46Cr 42Cr 79Cr 5.41TCr 80Cr 544.92Cr 212.9Cr 2.66TCr 210.91Cr 206.36Cr 9.2TCr P/E 2026 *
8.37x
P/E 2027 * 7.43x
Enterprise Value 380.41Cr 440.59Cr 56Cr 49Cr 46Cr 42Cr 79Cr 5.41TCr 80Cr 544.92Cr 212.9Cr 2.66TCr 210.91Cr 206.36Cr 9.2TCr EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.5x
Free-Float
45.7%
Yield 2026 *
5.39%
Yield 2027 * 6.06%
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
13/01 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
30/12 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day+2.33%
1 week-1.12%
Current month+10.00%
1 month+8.98%
3 months-8.81%
6 months-18.71%
Current year-20.18%
1 week 3.42
Extreme 3.42
3.59
1 month 3.07
Extreme 3.07
3.64
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.52
3 years 3.07
Extreme 3.07
7.41
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 43 28/11/2025
Director TitleAgeSince
Director/Board Member 69 12/06/2018
Director/Board Member 66 06/02/2026
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
+2.33%-1.12%-34.57%-49.28% 56Cr
-1.35%-0.82%-9.78%-5.01% 1.34TCr
-2.94%-3.76%-30.91%-51.42% 507.59Cr
-0.78%+1.50%-0.20%+1.50% 479.57Cr
-3.19%-0.61%+2.12%-33.44% 404.66Cr
-2.43%-3.43%+1.38%-8.93% 363.24Cr
-1.33%+1.56%-2.06%-4.14% 362.89Cr
-1.19%+2.47%-2.66%+9.52% 347.73Cr
-2.28%-0.77%-14.46%-24.61% 240.47Cr
-3.10%-2.19%-5.23%+40.09% 182.23Cr
Average -1.63%-2.96%-9.64%-12.57% 428.85Cr
Weighted average by Cap. -1.80%-2.82%-8.30%-11.30%

Financials

2026 *2027 *
Net sales 698.2Cr 808.66Cr 103.12Cr 91Cr 84Cr 77Cr 145.22Cr 9.93TCr 147.46Cr 1TCr 390.75Cr 4.88TCr 387.1Cr 378.76Cr 17TCr 756.3Cr 875.95Cr 111.7Cr 98Cr 91Cr 84Cr 157.3Cr 11TCr 159.73Cr 1.08TCr 423.26Cr 5.29TCr 419.31Cr 410.27Cr 18TCr
Net income 45Cr 53Cr 6.71Cr 5.9Cr 5.48Cr 5.03Cr 9.45Cr 646.42Cr 9.6Cr 65Cr 25Cr 317.8Cr 25Cr 25Cr 1.1TCr 51Cr 59Cr 7.58Cr 6.66Cr 6.19Cr 5.68Cr 11Cr 730.33Cr 11Cr 74Cr 29Cr 359.05Cr 28Cr 28Cr 1.24TCr
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
27/26/27 HK$3.520 +2.33% 5,53,000
24/26/24 HK$3.440 -0.86% 5,74,000
23/26/23 HK$3.470 -1.42% 4,96,000
22/26/22 HK$3.520 0.00% 6,01,000
21/26/21 HK$3.520 -1.12% 3,88,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.970CNY
Average target price
4.601CNY
Spread / Average Target
+54.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock